Published in Am J Physiol on September 01, 1992
Substance P in heart failure: the good and the bad. Int J Cardiol (2013) 1.97
A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children. Blood (2015) 1.44
Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome -- a randomized study (SYSDIET). J Intern Med (2013) 1.12
Clinical trials for cytoprotection in stroke. NeuroRx (2004) 1.08
Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia. Am J Med Sci (2009) 1.04
Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system. Surg Neurol Int (2012) 0.86
The role of magnesium deficiency in cardiovascular and intestinal inflammation. Magnes Res (2010) 0.84
Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia. Magnes Res (2009) 0.83
The nerve-heart connection in the pro-oxidant response to Mg-deficiency. Heart Fail Rev (2006) 0.83
Association of dietary magnesium intake with radiographic knee osteoarthritis: results from a population-based study. Arthritis Care Res (Hoboken) (2012) 0.81
The Association Between Admission Magnesium Concentrations and Lactic Acidosis in Critical Illness. J Intensive Care Med (2014) 0.81
Inflammation in acute CNS injury: a focus on the role of substance P. Br J Pharmacol (2015) 0.81
EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade. J Cardiovasc Pharmacol (2015) 0.80
Serum magnesium and stable asthma: Is there a link? Lung India (2010) 0.78
TRPM7 kinase activity regulates murine mast cell degranulation. J Physiol (2016) 0.76
The role of magnesium sulfate in the intensive care unit. EXCLI J (2017) 0.75
Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J (1969) 3.37
Autoimmunization with irradiated tumour cells in human malignant melanoma. Br Med J (1970) 2.91
Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet (1971) 2.22
Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N Engl J Med (1992) 1.90
Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol (2001) 1.87
Immunologic function and survival in hemodialysis patients. Kidney Int (1998) 1.82
Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol (1998) 1.80
The specificity of surface membrane immunofluorescence in human malignant melanoma. Int J Cancer (1972) 1.75
Circulating immune complexes in schistosomiasis due to Schistosoma mansoni. Br Med J (1975) 1.51
Presence of anti-pituitary hormone antibodies in patients with empty sella syndrome and pituitary tumours. Clin Endocrinol (Oxf) (1993) 1.49
Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem (1992) 1.18
Epstein-Barr virus shedding by astronauts during space flight. Brain Behav Immun (2005) 1.16
Herpes simplex type 2 encephalitis concurrent with known cerebral metastases. Acta Neuropathol (1979) 1.13
Target role of Langerhans cells in mycosis fungoides: transmission and immuno-electron microscopic studies. J Cutan Pathol (1979) 1.10
Dyadic relationship conflict, gender, and mortality in urban hemodialysis patients. J Am Soc Nephrol (2000) 1.03
Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine (2001) 1.02
Immunoregulation by neuropeptides in magnesium deficiency: ex vivo effect of enhanced substance P production on circulating T lymphocytes from magnesium-deficient mice. Magnes Res (1996) 0.99
Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition. Circ Res (1994) 0.98
Microvascular assessment of burn depth conversion during varying resuscitation conditions. J Burn Care Rehabil (2001) 0.97
HIV-associated immune-mediated renal disease. Kidney Int (1993) 0.97
Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol (1985) 0.95
Stereoselective reduction of pyruvate by sodium borohydride catalyzed by pyruvate kinase. Biochim Biophys Acta (1973) 0.95
Immunological associations of the halo naevus with cutaneous malignant melanoma. Br J Dermatol (1973) 0.94
Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition. Mol Cell Biochem (1994) 0.94
Unilateral megalencephaly, cerebral cortical dysplasia, neuronal hypertrophy, and heterotopia: cytomorphometric, fluorometric cytochemical, and biochemical analyses. Acta Neuropathol (1979) 0.93
A system of immunofluorescence in the study of tumour cells. Rev Eur Etud Clin Biol (1970) 0.93
Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes (1990) 0.92
Possible explanation for loss of detectable antibody in patients with disseminated malignant melanoma. Nature (1971) 0.92
The 2003 Carl A Moyer Award: real-time metabolic monitors, ischemia-reperfusion, titration endpoints, and ultraprecise burn resuscitation. J Burn Care Rehabil (2004) 0.91
Separation of two distinct tumor-associated antibodies in the serum of melanoma patients. J Natl Cancer Inst (1972) 0.91
Update on topical cyclosporin A. Background, immunology, and pharmacology. Cornea (1990) 0.90
Ia antigens on indeterminate cells of the epidermis: immunoelectronmicroscopic studies of surface antigens. Br J Dermatol (1979) 0.90
Magnesium-deficiency-enhanced post-ischemic myocardial injury is reduced by substance P receptor blockade. J Mol Cell Cardiol (1997) 0.89
Characterization of the fertilization antigen 1 for the development of a contraceptive vaccine. Proc Natl Acad Sci U S A (1986) 0.88
Effect of renal replacement therapy on cellular cytokine production in patients with renal disease. Kidney Int (1990) 0.88
Immune complex arthritis in a patient with Schistosoma mansoni infection. Arthritis Rheum (1986) 0.88
Immune complexes in human melanoma: a consequence of deranged immune regulation. Scand J Immunol (1976) 0.88
Activation of the neutrophil and loss of plasma glutathione during Mg-deficiency--modulation by nitric oxide synthase inhibition. Mol Cell Biochem (1997) 0.86
Response of interleukin-1beta in the magnocellular system to salt-loading. J Neuroendocrinol (2006) 0.84
Inverse correlation between age related abnormalities of T-cell immunity and circulating thymosin alpha 1 levels in haemophilia A. Br J Haematol (1984) 0.84
VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death. Brain Res (1999) 0.83
Cytokines, neuropeptides, and reperfusion injury during magnesium deficiency. Ann N Y Acad Sci (1994) 0.82
Regional variation in the levels of transferrin in the CNS of normal and myelin-deficient rats. J Neurochem (1987) 0.82
Tumor-associated antigens in human malignant melanoma. Yale J Biol Med (1973) 0.82
Interferons and cerebral palsy. J Pediatr (1999) 0.82
Thymic functions in uremic rats: evidence for thymosin alpha 1 deficiency. Nephron (1985) 0.82
Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide. Ann N Y Acad Sci (1997) 0.81
Cu/Zn superoxide dismutase free radicals, and motoneuron disease. Lancet (1993) 0.81
Sperm antibodies in vasectomized men and their effects on fertilization. Biol Reprod (1989) 0.81
A method for elution of immunoglobulin from the surface of living cells. Rev Eur Etud Clin Biol (1971) 0.81
Regression of canine mammary carcinoma after immunoadsorption therapy. Cancer Res (1982) 0.80
Acute myelomonocytic leukemia associated with nephrotic syndrome. A case report with immunological studies. Nephron (1983) 0.80
The effects of intravenous phytohaemagglutinin in a patient with disseminated malignant melanoma: a clinical and immunological study. Rev Eur Etud Clin Biol (1971) 0.79
Cholinergic mechanisms of cutaneous active vasodilation during heat stress in cystic fibrosis. J Appl Physiol (1985) (2007) 0.79
Primary Mycobacterium avium complex infections correlate with lowered cellular immune reactivity in Matschie's tree kangaroos (Dendrolagus matschiei). J Infect Dis (1998) 0.79
Interleukin-1beta release in the supraoptic nucleus area during osmotic stimulation requires neural function. J Neuroendocrinol (2008) 0.79
Antigen--antibody complexes related to the baboon endogenous virus in humans with acute lymphoblastic leukemia--hand mirror variant (ALL-HMC). Blood (1980) 0.79
Zinc modulates mononuclear cellular calcitriol metabolism in peritoneal dialysis patients. Kidney Int (1996) 0.78
Chemokines released from astroglia by vasoactive intestinal peptide. Mechanism of neuroprotection from HIV envelope protein toxicity. Ann N Y Acad Sci (2000) 0.78
Membranoproliferative glomerulonephritis in a patient treated with interferon-alpha for human immunodeficiency virus infection. Am J Kidney Dis (1994) 0.78
Vasoactive intestinal peptide. Link between electrical activity and glia-mediated neurotrophism. Ann N Y Acad Sci (1999) 0.78
Novel membrane target proteins for lipoxygenase-derived mono(S)hydroxy fatty acids. Biochim Biophys Acta (1999) 0.77
Eosinophilia and cellular cytokine responsiveness in hemodialysis patients. J Am Soc Nephrol (1992) 0.77
Zinc balance in combined zinc deficiency and uremia. Kidney Int (1988) 0.76
Protein A-coated glass beads. Universal support medium for high-performance immunoaffinity chromatography. J Chromatogr (1985) 0.76
The effect of muscle flap transposition to the fracture site on TNFalpha levels during fracture healing. Plast Reconstr Surg (2000) 0.76
Concomitant erythrasma and dermatophytosis of the groin. Br J Dermatol (1979) 0.76
Vasoactive intestinal peptide releases interleukin-1 from astrocytes. Ann N Y Acad Sci (1996) 0.76
The detection of anti-cholinesterase antibodies in myasthenia gravis. Ann N Y Acad Sci (1981) 0.76
Acute lymphoblastic leukemia--hand mirror variant--viral immune interrelationship as demonstrated by ultrastructural studies. Am J Hematol (1981) 0.76
Regulation of stimulated cyclic AMP synthesis by urocanic acid. Photochem Photobiol (1998) 0.76
Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion. J Clin Oncol (1986) 0.76
Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J Womens Health Gend Based Med (1999) 0.76
Use of avidin-coated glass beads as a support for high-performance immunoaffinity chromatography. J Chromatogr (1988) 0.76
Editorial response to author review in publishing science. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.75
Isolation and quantitation of serum IgE levels by high-performance immunoaffinity chromatography. J Chromatogr (1985) 0.75
Gastric carcinoma and thrombotic thrombocytopenic purpura: association with plasma immune complex concentrations. Br Med J (Clin Res Ed) (1982) 0.75
Inhibition of tumor necrosis factor-alpha by thalidomide in magnesium deficiency. Mol Cell Biochem (1993) 0.75
Cellular localization of immunoglobulin within human maglignant melanomata. Br J Cancer (1976) 0.75
Recombinant leukocyte A interferon in B-cell chronic lymphocytic leukemia: in vivo effects on autologous antitumor immunity. J Biol Response Mod (1985) 0.75
A defect in the formation of uropod-bearing lymphocytes (hand-mirror cells) in patients with the Wiskott-Aldrich syndrome. Am J Hematol (1981) 0.75
Specificity of tumor-associated antibodies in sera of patients with uveal melanoma. Can J Ophthalmol (1978) 0.75
Immune complexes in transitional cell carcinoma. J Urol (1980) 0.75
[The influence of humoral immune mechanisms on metastasizing tumors in humans (author's transl)]. MMW Munch Med Wochenschr (1977) 0.75
Immunological approach to cancer therapy. Lancet (1971) 0.75
Serial studies of free radical and antioxidant activity in motor neurone disease and the effect of selegiline. Neurodegeneration (1995) 0.75
Studies of immunological parameters in minimal change nephrotic syndrome. Ann Allergy (1981) 0.75
The role of altered vascular permeability in recurrent uveitis. Int Ophthalmol (1981) 0.75
Immune derangement in patients with malignant melanoma. J Cutan Pathol (1979) 0.75
Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels. Blood Purif (2001) 0.75
Immune reactions in patients with bladder and prostatic cancer. Aust N Z J Surg (1978) 0.75
Proceedings: The isolation of specific antigens by affinity chromatography. Trans R Soc Trop Med Hyg (1975) 0.75
Expression of ia antigens by murine keratinizing epithelial langerhans cells. Immunogenetics (1978) 0.75
[Replication of immune RNA by human lymphoblastoid cells]. C R Acad Sci Hebd Seances Acad Sci D (1977) 0.75
Proceedings: Preliminary observations on countercurrent immuno-electrophoresis of Trypanosoma cruzi and Leishmania. Trans R Soc Trop Med Hyg (1975) 0.75
Immunising against receptors for antigen. Lancet (1976) 0.75
Hand-mirror cells in acute lymphoblastic leukemia. Am J Clin Pathol (1981) 0.75